Tue, 26 Jan 2010 13:09:01 -0500 PeerView Oncology CME/CNE/CPE Audio Podcast PVI, PeerView Institute for Medical Education http://www.peerviewpress.com Podcast Maker v1.3.8b - http://www.lemonzdream.com/podcastmaker Thought leader perspectives on current clinical advances in medicine PeerView Press is an independent, professional medical publishing company focused on gathering and reporting information pertaining to clinically relevant advances and developments in the science and practice of medicine. As publishers of PeerView Publications, PeerView Press is solely responsible for the selection of publication topics, the preparation of editorial content and the distribution of all materials it publishes. en 2007 PeerView Press, 24 West 40th Street, Suite 950, New York, NY 10018 webmaster@peerviewpress.com http://media.peerviewpress.com/000136/podcast/pvi/xml/podcast_oncologyCME-CNE-CPE_144.jpg PeerView Oncology CME/CNE/CPE Audio Podcast http://www.peerviewpress.com 144 144 Science & Medicine CME, Medical Education, continuing medical education, CME credits, PeerView Press, inSession, inReview, CE, Oncology no Axel Grothey, MD - Exploring the Oncologist's Tool Kit in Advanced CRC: Considerations for Optimizing Care PVI, PeerView Institute for Medical Education Please be sure to view the accompanying (PDF) file for full CME/CNE/CPE information. Please be sure to view the accompanying (PDF) file for full CME/CNE/CPE information. http://media.peerviewpress.com/000136/podcast/pvi/mp3/PPVNE07423e81.mp3 Thu, 02 Feb 2012 10:25:46 -0500 Science, Medicine no 00:40:44 CME/CNE/CPE Information - Exploring the Oncologist's Tool Kit in Advanced CRC: Considerations for Optimizing Care PVI, PeerView Institute for Medical Education Please view this PDF file for full CME/CNE/CPE information. You will need Adobe Acrobat software to access this file. Please view this PDF file for full CME/CNE/CPE information. You will need Adobe Acrobat software to access this file. http://media.peerviewpress.com/000136/podcast/pvi/pdf/PPVNE07423CMEinfo.pdf Thu, 02 Feb 2012 10:25:45 -0500 Science, Medicine no 00:00:00 Pasquale Patrizio, MD, MBE - Integrating Best Practices for Fertility Preservation Into Routines of Cancer Care PVI, PeerView Institute for Medical Education Please be sure to view the accompanying (PDF) file for full CME/CNE/CPE information. Please be sure to view the accompanying (PDF) file for full CME/CNE/CPE information. http://media.peerviewpress.com/000136/podcast/pvi/mp3/150200807e83.mp3 Tue, 31 Jan 2012 13:25:44 -0500 Science, Medicine no 00:33:11 CME/CNE/CPE Information - Integrating Best Practices for Fertility Preservation Into Routines of Cancer Care PVI, PeerView Institute for Medical Education Please view this PDF file for full CME/CNE/CPE information. You will need Adobe Acrobat software to access this file. Please view this PDF file for full CME/CNE/CPE information. You will need Adobe Acrobat software to access this file. http://media.peerviewpress.com/000136/podcast/pvi/pdf/150200807CMEinfo.pdf Tue, 31 Jan 2012 13:25:44 -0500 Science, Medicine no 00:00:00 Farhad Ravandi-Kashani, MD - A New Wave of Therapy in Adult AML? Individualized Treatment Strategies and the Implications of New Science PVI, PeerView Institute for Medical Education Please be sure to view the accompanying (PDF) file for full CME/CNE/CPE information. Please be sure to view the accompanying (PDF) file for full CME/CNE/CPE information. http://media.peerviewpress.com/000136/podcast/pvi/mp3/150200578r213.mp3 Fri, 30 Dec 2011 13:25:49 -0500 Science, Medicine no 00:28:13 CME/CNE/CPE Information - A New Wave of Therapy in Adult AML? Individualized Treatment Strategies and the Implications of New Science PVI, PeerView Institute for Medical Education Please view this PDF file for full CME/CNE/CPE information. You will need Adobe Acrobat software to access this file. Please view this PDF file for full CME/CNE/CPE information. You will need Adobe Acrobat software to access this file. http://media.peerviewpress.com/000136/podcast/pvi/pdf/150200578CMEinfo.pdf Fri, 30 Dec 2011 13:25:45 -0500 Science, Medicine no 00:00:00 Robert J. Motzer, MD - Advanced Renal Cell Carcinoma: A Practical Evaluation of Current and Emerging Therapeutic Options PVI, PeerView Institute for Medical Education Please be sure to view the accompanying (PDF) file for full CME/CNE/CPE information. Please be sure to view the accompanying (PDF) file for full CME/CNE/CPE information. http://media.peerviewpress.com/000136/podcast/pvi/mp3/150200163r216.mp3 Mon, 12 Dec 2011 13:25:46 -0500 Science, Medicine no 00:28:53 CME/CNE/CPE Information - Advanced Renal Cell Carcinoma: A Practical Evaluation of Current and Emerging Therapeutic Options PVI, PeerView Institute for Medical Education Please view this PDF file for full CME/CNE/CPE information. You will need Adobe Acrobat software to access this file. Please view this PDF file for full CME/CNE/CPE information. You will need Adobe Acrobat software to access this file. http://media.peerviewpress.com/000136/podcast/pvi/pdf/150200163CMEinfo.pdf Mon, 12 Dec 2011 13:25:45 -0500 Science, Medicine no 00:00:00 Mark G. Kris, MD - New Frontiers in NSCLC: The Implications of Emerging Data and Novel Therapeutics for Personalized Medicine PVI, PeerView Institute for Medical Education Please be sure to view the accompanying (PDF) file for full CME/CNE/CPE information. Please be sure to view the accompanying (PDF) file for full CME/CNE/CPE information. http://media.peerviewpress.com/000136/podcast/pvi/mp3/PPVNE07432d5.mp3 Tue, 29 Nov 2011 13:25:49 -0500 Science, Medicine no 00:49:40 CME/CNE/CPE Information - New Frontiers in NSCLC: The Implications of Emerging Data and Novel Therapeutics for Personalized Medicine PVI, PeerView Institute for Medical Education Please view this PDF file for full CME/CNE/CPE information. You will need Adobe Acrobat software to access this file. Please view this PDF file for full CME/CNE/CPE information. You will need Adobe Acrobat software to access this file. http://media.peerviewpress.com/000136/podcast/pvi/pdf/PPVNE07432CMEinfo.pdf Tue, 29 Nov 2011 13:25:45 -0500 Science, Medicine no 00:00:00 Corey J. Langer, MD - The Modern, Individualized Management of NSCLC: What Defines Optimal Therapy? PVI, PeerView Institute for Medical Education Please be sure to view the accompanying (PDF) file for full CME/CNE/CPE information. Please be sure to view the accompanying (PDF) file for full CME/CNE/CPE information. http://media.peerviewpress.com/000136/podcast/pvi/mp3/PPVNE07369r210.mp3 Wed, 23 Nov 2011 13:25:46 -0500 Science, Medicine no 00:32:55 CME/CNE/CPE Information - The Modern, Individualized Management of NSCLC: What Defines Optimal Therapy? PVI, PeerView Institute for Medical Education Please view this PDF file for full CME/CNE/CPE information. You will need Adobe Acrobat software to access this file. Please view this PDF file for full CME/CNE/CPE information. You will need Adobe Acrobat software to access this file. http://media.peerviewpress.com/000136/podcast/pvi/pdf/PPVNE07369CMEinfo.pdf Wed, 23 Nov 2011 13:25:45 -0500 Science, Medicine no 00:00:00 John P. Leonard, MD - Key Findings in Lymphoid Malignancies: Using New Data to Improve Care in NHL and CLL PVI, PeerView Institute for Medical Education Please be sure to view the accompanying (PDF) file for full CME/CNE/CPE information. Please be sure to view the accompanying (PDF) file for full CME/CNE/CPE information. http://media.peerviewpress.com/000136/podcast/pvi/mp3/150200065r208.mp3 Tue, 22 Nov 2011 13:25:49 -0500 Science, Medicine no 00:33:53 CME/CNE/CPE Information - Key Findings in Lymphoid Malignancies: Using New Data to Improve Care in NHL and CLL PVI, PeerView Institute for Medical Education Please view this PDF file for full CME/CNE/CPE information. You will need Adobe Acrobat software to access this file. Please view this PDF file for full CME/CNE/CPE information. You will need Adobe Acrobat software to access this file. http://media.peerviewpress.com/000136/podcast/pvi/pdf/150200065CMEinfo.pdf Tue, 22 Nov 2011 13:25:45 -0500 Science, Medicine no 00:00:00 Michael W. N. Deininger, MD, PhD - Using Innovative Therapy in CML: Interactive Case Discussions on Evolving Targeted Options PVI, PeerView Institute for Medical Education Please be sure to view the accompanying (PDF) file for full CME/CNE/CPE information. Please be sure to view the accompanying (PDF) file for full CME/CNE/CPE information. http://media.peerviewpress.com/000136/podcast/pvi/mp3/PPVNE07422e69.mp3 Mon, 22 Aug 2011 13:25:49 -0500 Science, Medicine no 00:31:15 CME/CNE/CPE Information - Using Innovative Therapy in CML: Interactive Case Discussions on Evolving Targeted Options PVI, PeerView Institute for Medical Education Please view this PDF file for full CME/CNE/CPE information. You will need Adobe Acrobat software to access this file. Please view this PDF file for full CME/CNE/CPE information. You will need Adobe Acrobat software to access this file. http://media.peerviewpress.com/000136/podcast/pvi/pdf/PPVNE07422CMEinfo.pdf Mon, 22 Aug 2011 13:25:45 -0500 Science, Medicine no 00:00:00 Mark G. Kris, MD - Preventing Chemotherapy-Related Nausea and Emesis: New Guidelines, Practical Recommendations, and Optimizing Care PVI, PeerView Institute for Medical Education Please be sure to view the accompanying (PDF) file for full CME/CNE/CPE information. Please be sure to view the accompanying (PDF) file for full CME/CNE/CPE information. http://media.peerviewpress.com/000136/podcast/pvi/mp3/PPVNE07552r188.mp3 Wed, 17 Aug 2011 13:25:49 -0500 Science, Medicine no 00:27:26 CME/CNE/CPE Information - Preventing Chemotherapy-Related Nausea and Emesis: New Guidelines, Practical Recommendations, and Optimizing Care PVI, PeerView Institute for Medical Education Please view this PDF file for full CME/CNE/CPE information. You will need Adobe Acrobat software to access this file. Please view this PDF file for full CME/CNE/CPE information. You will need Adobe Acrobat software to access this file. http://media.peerviewpress.com/000136/podcast/pvi/pdf/PPVNE07552CMEinfo.pdf Wed, 17 Aug 2011 13:25:45 -0500 Science, Medicine no 00:00:00 Antoni Ribas, MD - The Future Is Now in Melanoma: Exploring Strategies for Innovative Care Based on New Science PVI, PeerView Institute for Medical Education Please be sure to view the accompanying (PDF) file for full CME/CNE/CPE information. Please be sure to view the accompanying (PDF) file for full CME/CNE/CPE information. http://media.peerviewpress.com/000136/podcast/pvi/mp3/PPVNE07465d1.mp3 Thu, 14 Jul 2011 13:25:49 -0500 Science, Medicine no 01:10:22 Melanoma, CNS metastases, ipilimumab, gp100 vaccine, immunosuppressive, BRAF, NRAS, vemurafenib, MEK, peginterferon CME/CNE/CPE Information - The Future Is Now in Melanoma: Exploring Strategies for Innovative Care Based on New Science PVI, PeerView Institute for Medical Education Please view this PDF file for full CME/CNE/CPE information. You will need Adobe Acrobat software to access this file. Please view this PDF file for full CME/CNE/CPE information. You will need Adobe Acrobat software to access this file. http://media.peerviewpress.com/000136/podcast/pvi/pdf/PPVNE07465CMEinfo.pdf Thu, 14 Jul 2011 13:25:49 -0500 Science, Medicine no 00:00:00 Melanoma, CNS metastases, ipilimumab, gp100 vaccine, immunosuppressive, BRAF, NRAS, vemurafenib, MEK, peginterferon Jedd D. Wolchok, MD, PhD, - Novel Immunotherapy in Malignant Melanoma: Changing the Nature of Modern Treatment PVI, PeerView Institute for Medical Education Please be sure to view the accompanying (PDF) file for full CME/CNE/CPE information. Please be sure to view the accompanying (PDF) file for full CME/CNE/CPE information. http://media.peerviewpress.com/000136/podcast/pvi/mp3/PPVNE07409e60.mp3 Thu, 19 May 2011 13:25:49 -0500 Science, Medicine no 00:22:50 Melanoma, skin, cancer, immunotherapy, CTLA-4, BRAF, PD1, MEK, ipilumumab, systemic, dacarbazine, temozolomide CME/CNE/CPE Information - Novel Immunotherapy in Malignant Melanoma: Changing the Nature of Modern Treatment PVI, PeerView Institute for Medical Education Please view this PDF file for full CME/CNE/CPE information. You will need Adobe Acrobat software to access this file. Please view this PDF file for full CME/CNE/CPE information. You will need Adobe Acrobat software to access this file. http://media.peerviewpress.com/000136/podcast/pvi/pdf/PPVNE07409CMEinfo.pdf Thu, 19 May 2011 13:25:49 -0500 Science, Medicine no 00:00:00 Melanoma, skin, cancer, immunotherapy, CTLA-4, BRAF, PD1, MEK, ipilumumab, systemic, dacarbazine, temozolomide Maureen F. Zakowski, MD - Challenging Cases for Pathologists: Optimal Biospecimen Collection and Storage, Histologic and Molecular Diagnosis, and Individualized Treatment Selection in NSCLC PVI, PeerView Institute for Medical Education Please be sure to view the accompanying (PDF) file for full CME/CNE/CPE information. Please be sure to view the accompanying (PDF) file for full CME/CNE/CPE information. http://media.peerviewpress.com/000136/podcast/pvi/mp3/PPVNE07370p38.mp3 Mon, 02 May 2011 13:25:49 -0500 Science, Medicine no 00:26:52 pathology, histology, lung, molecular markers, mutational, immunohistochemical, non-small cell lung cancer, squamous, carcinoma, adenocarcinoma, biopsy CME/CNE/CPE Information - Challenging Cases for Pathologists: Optimal Biospecimen Collection and Storage, Histologic and Molecular Diagnosis, and Individualized Treatment Selection in NSCLC PVI, PeerView Institute for Medical Education Please view this PDF file for full CME/CNE/CPE information. You will need Adobe Acrobat software to access this file. Please view this PDF file for full CME/CNE/CPE information. You will need Adobe Acrobat software to access this file. http://media.peerviewpress.com/000136/podcast/pvi/pdf/PPVNE07370CMEinfo.pdf Mon, 02 May 2011 13:25:45 -0500 Science, Medicine no 00:00:00 pathology, histology, lung, molecular markers, mutational, immunohistochemical, non-small cell lung cancer, squamous, carcinoma, adenocarcinoma, biopsy Vincent A. Miller, MD - Virtual NSCLC Tumor Board: Interactive Cases on Personalizing Care Through the Application of Molecular Medicine PVI, PeerView Institute for Medical Education Please be sure to view the accompanying (PDF) file for full CME/CNE/CPE information. Please be sure to view the accompanying (PDF) file for full CME/CNE/CPE information. http://media.peerviewpress.com/000136/podcast/pvi/mp3/PPVNE07190e65.mp3 Thu, 24 Mar 2011 13:25:49 -0500 Science, Medicine no 00:51:46 Lung cancer, NSCLC, NOS, histology, EGFR, KRAS, TTF-1, napsin-A, p63, multidisciplinary, ALK CME/CNE/CPE Information - Virtual NSCLC Tumor Board: Interactive Cases on Personalizing Care Through the Application of Molecular Medicine PVI, PeerView Institute for Medical Education Please view this PDF file for full CME/CNE/CPE information. You will need Adobe Acrobat software to access this file. Please view this PDF file for full CME/CNE/CPE information. You will need Adobe Acrobat software to access this file. http://media.peerviewpress.com/000136/podcast/pvi/pdf/PPVNE07190CMEinfo.pdf Thu, 24 Mar 2011 13:25:45 -0500 Science, Medicine no 00:00:00 Lung cancer, NSCLC, NOS, histology, EGFR, KRAS, TTF-1, napsin-A, p63, multidisciplinary, ALK John P. Leonard, MD - Innovative Therapy for NHL and CLL: How Cutting-Edge Research Is Influencing Modern Management PVI, PeerView Institute for Medical Education Please be sure to view the accompanying (PDF) file for full CME/CNE/CPE information. Please be sure to view the accompanying (PDF) file for full CME/CNE/CPE information. http://media.peerviewpress.com/000136/podcast/pvi/mp3/PPVNE07235e66.mp3 Thu, 31 Mar 2011 13:25:49 -0500 Science, Medicine no 00:45:42 NHL, follicular lymphoma, CLL, leukemia, R-CHOP, FCR, RIT, DLBCL, MCL CME/CNE/CPE Information - Innovative Therapy for NHL and CLL: How Cutting-Edge Research Is Influencing Modern Management PVI, PeerView Institute for Medical Education Please view this PDF file for full CME/CNE/CPE information. You will need Adobe Acrobat software to access this file. Please view this PDF file for full CME/CNE/CPE information. You will need Adobe Acrobat software to access this file. http://media.peerviewpress.com/000136/podcast/pvi/pdf/PPVNE07235CMEinfo.pdf Thu, 31 Mar 2011 13:25:45 -0500 Science, Medicine no 00:00:00 NHL, follicular lymphoma, CLL, leukemia, R-CHOP, FCR, RIT, DLBCL, MCL Gail J. Roboz, MD - Evaluating Research-Driven Therapeutic Advances in Hematologic Malignancies PVI, PeerView Institute for Medical Education Please be sure to view the accompanying (PDF) file for full CME/CNE/CPE information. Please be sure to view the accompanying (PDF) file for full CME/CNE/CPE information. http://media.peerviewpress.com/000136/podcast/pvi/mp3/PPVNE07172s182.mp3 Tue, 29 Mar 2011 13:25:49 -0500 Science, Medicine no 00:47:26 ASH 2010, NHL, CLL, AML, MDS, myeloma, immunotherapy, MDAS CME/CNE/CPE Information - Evaluating Research-Driven Therapeutic Advances in Hematologic Malignancies PVI, PeerView Institute for Medical Education Please view this PDF file for full CME/CNE/CPE information. You will need Adobe Acrobat software to access this file. Please view this PDF file for full CME/CNE/CPE information. You will need Adobe Acrobat software to access this file. http://media.peerviewpress.com/000136/podcast/pvi/pdf/PPVNE07172CMEinfo.pdf Tue, 29 Mar 2011 13:25:45 -0500 Science, Medicine no 00:00:00 ASH 2010, NHL, CLL, AML, MDS, myeloma, immunotherapy, MDAS Sagar Lonial, MD - Evaluating the Next Generation of Salvage Regimens and Active Therapeutics in Multiple Myeloma PVI, PeerView Institute for Medical Education Please be sure to view the accompanying (PDF) file for full CME/CNE/CPE information. Please be sure to view the accompanying (PDF) file for full CME/CNE/CPE information. http://media.peerviewpress.com/000136/podcast/pvi/mp3/PPVNE07124r171.mp3 Tue, 08 Mar 2011 13:25:49 -0500 Science, Medicine no 00:26:57 Myeloma, NCCN, bortezomib, pegylated liposomal doxorubicin, HDAC, IMiD, pomalidomide, carfilzomib CME/CNE/CPE Information - Evaluating the Next Generation of Salvage Regimens and Active Therapeutics in Multiple Myeloma PVI, PeerView Institute for Medical Education Please view this PDF file for full CME/CNE/CPE information. You will need Adobe Acrobat software to access this file. Please view this PDF file for full CME/CNE/CPE information. You will need Adobe Acrobat software to access this file. http://media.peerviewpress.com/000136/podcast/pvi/pdf/PPVNE07124CMEinfo.pdf Tue, 08 Mar 2011 13:25:45 -0500 Science, Medicine no 00:00:00 Myeloma, NCCN, bortezomib, pegylated liposomal doxorubicin, HDAC, IMiD, pomalidomide, carfilzomib Margaret von Mehren, MD - The Modern Approach to Soft-Tissue and Bone Sarcomas: Is Innovative Therapy Possible? PVI, PeerView Institute for Medical Education Please be sure to view the accompanying (PDF) file for full CME/CNE/CPE information. Please be sure to view the accompanying (PDF) file for full CME/CNE/CPE information. http://media.peerviewpress.com/000136/podcast/pvi/mp3/PPVNE07062r161.mp3 Mon, 07 Feb 2011 13:25:49 -0500 Science, Medicine no 00:32:54 soft-tissue, bone sarcoma, STS, Ewing's, hyperthermia, radiotherapy, gemcitabine, ridaforolimus, trabectedin, pazopanib CME/CNE/CPE Information - The Modern Approach to Soft-Tissue and Bone Sarcomas: Is Innovative Therapy Possible? PVI, PeerView Institute for Medical Education Please view this PDF file for full CME/CNE/CPE information. You will need Adobe Acrobat software to access this file. Please view this PDF file for full CME/CNE/CPE information. You will need Adobe Acrobat software to access this file. http://media.peerviewpress.com/000136/podcast/pvi/pdf/PPVNE07062CMEinfo.pdf Mon, 07 Feb 2011 13:25:45 -0500 Science, Medicine no 00:00:00 soft-tissue, bone sarcoma, STS, Ewing's, hyperthermia, radiotherapy, gemcitabine, ridaforolimus, trabectedin, pazopanib Koyamangalath Krishnan, MD, FRCP, FACP - Implementing Risk-Based Management of TLS: Challenging Cases for the Hematology-Oncology Team PVI, PeerView Institute for Medical Education Please be sure to view the accompanying (PDF) file for full CME/CNE/CPE information. Please be sure to view the accompanying (PDF) file for full CME/CNE/CPE information. http://media.peerviewpress.com/000136/podcast/pvi/mp3/PPVNE06802p36.mp3 Thu, 20 Jan 2011 13:25:49 -0500 Science, Medicine no 00:21:02 tumor lysis syndrome, TLS, CLL, risk stratification, allopurinol, rasburicase, staging FCR, hyperuricemia CME/CNE/CPE Information - Implementing Risk-Based Management of TLS: Challenging Cases for the Hematology-Oncology Team PVI, PeerView Institute for Medical Education Please view this PDF file for full CME/CNE/CPE information. You will need Adobe Acrobat software to access this file. Please view this PDF file for full CME/CNE/CPE information. You will need Adobe Acrobat software to access this file. http://media.peerviewpress.com/000136/podcast/pvi/pdf/PPVNE06802CMEinfo.pdf Thu, 20 Jan 2011 13:25:45 -0500 Science, Medicine no 00:00:00 tumor lysis syndrome, TLS, CLL, risk stratification, allopurinol, rasburicase, staging FCR, hyperuricemia Mark R. Gilbert, MD - Making a Difference: Practical Strategies for Improving Patient Accrual Into Neuro-Oncology Clinical Trials PVI, PeerView Institute for Medical Education Please be sure to view the accompanying (PDF) file for full CME/CNE/CPE information. Please be sure to view the accompanying (PDF) file for full CME/CNE/CPE information. http://media.peerviewpress.com/000136/podcast/pvi/mp3/PPVNE06717r138.mp3 Thu, 30 Dec 2010 13:25:49 -0500 Science, Medicine no 00:15:25 CNS, glioma, glioblastoma, radiotherapy, temozolomide, clinical trial accrual, enrollment, neuro-onc, brain CME/CNE/CPE Information - Making a Difference: Practical Strategies for Improving Patient Accrual Into Neuro-Oncology Clinical Trials PVI, PeerView Institute for Medical Education Please view this PDF file for full CME/CNE/CPE information. You will need Adobe Acrobat software to access this file. Please view this PDF file for full CME/CNE/CPE information. You will need Adobe Acrobat software to access this file. http://media.peerviewpress.com/000136/podcast/pvi/pdf/PPVNE06717CMEinfo.pdf Thu, 30 Dec 2010 13:25:45 -0500 Science, Medicine no 00:00:00 CNS, glioma, glioblastoma, radiotherapy, temozolomide, clinical trial accrual, enrollment, neuro-onc, brain Robert A. Burger, MD and Joyce O'Shaughnessy, MD - Exploring State-of-the-Art Science in Solid Tumors: An Update From Milan on Therapeutic Advances in Breast and Ovarian Cancer PVI, PeerView Institute for Medical Education Please be sure to view the accompanying (PDF) file for full CME/CNE/CPE information. Please be sure to view the accompanying (PDF) file for full CME/CNE/CPE information. http://media.peerviewpress.com/000136/podcast/pvi/mp3/PPVNE07157s178.mp3 Wed, 22 Dec 2010 13:25:49 -0500 Science, Medicine no 00:27:38 breast cancer, ovarian cancer, solid tumors, ESMO, targeted therapy, cytotoxic agents, antiangiogenic agents, PARP inhibitors, HER2-positive, T-DM1, trastuzumab, lapatinib, bevacizumab, paclitaxel, iniparib, olaparib, hedgehog pathway CME/CNE/CPE Information - Exploring State-of-the-Art Science in Solid Tumors: An Update From Milan on Therapeutic Advances in Breast and Ovarian Cancer PVI, PeerView Institute for Medical Education Please view this PDF file for full CME/CNE/CPE information. You will need Adobe Acrobat software to access this file. Please view this PDF file for full CME/CNE/CPE information. You will need Adobe Acrobat software to access this file. http://media.peerviewpress.com/000136/podcast/pvi/pdf/PPVNE07157CMEinfo.pdf Wed, 22 Dec 2010 13:25:45 -0500 Science, Medicine no 00:00:00 breast cancer, ovarian cancer, solid tumors, ESMO, targeted therapy, cytotoxic agents, antiangiogenic agents, PARP inhibitors, HER2-positive, T-DM1, trastuzumab, lapatinib, bevacizumab, paclitaxel, iniparib, olaparib, hedgehog pathway Deborah K. Armstrong, MD - Optimal Strategies for Treatment of Advanced Ovarian Cancer: A Case-Based Approach PVI, PeerView Institute for Medical Education Please be sure to view the accompanying (PDF) file for full CME/CNE/CPE information. Please be sure to view the accompanying (PDF) file for full CME/CNE/CPE information. http://media.peerviewpress.com/000136/podcast/pvi/mp3/PPVNE06674p21.mp3 Fri, 10 Dec 2010 13:25:49 -0500 Science, Medicine no 00:32:50 ovarian cancer, OC, gynecologic, bevacizumab, VEGF, chemotherapy, CA-125, BRCA, pegylated liposomal doxorubicin CME/CNE/CPE Information - Optimal Strategies for Treatment of Advanced Ovarian Cancer: A Case-Based Approach PVI, PeerView Institute for Medical Education Please view this PDF file for full CME/CNE/CPE information. You will need Adobe Acrobat software to access this file. Please view this PDF file for full CME/CNE/CPE information. You will need Adobe Acrobat software to access this file. http://media.peerviewpress.com/000136/podcast/pvi/pdf/PPVNE06674CMEinfo.pdf Fri, 10 Dec 2010 13:25:45 -0500 Science, Medicine no 00:00:00 ovarian cancer, OC, gynecologic, bevacizumab, VEGF, chemotherapy, CA-125, BRCA, pegylated liposomal doxorubicin Marvin Dewar, MD - Educating Physicians About Modern-Day Education: Dispelling The Myths and Providing The Facts About Commercially Supported CME PVI, PeerView Institute for Medical Education Please be sure to view the accompanying (PDF) file for full CME/CNE/CPE information. Please be sure to view the accompanying (PDF) file for full CME/CNE/CPE information. http://media.peerviewpress.com/000136/podcast/pvi/mp3/PPVNE06015ModernCME.mp3 Tue, 30 Nov 2010 13:25:49 -0500 Science, Medicine no 00:26:27 CME, rules, regulations, FDA, promotional activities, ACCME, standards, commercial support, NFEI, bias CME/CNE/CPE Information - Educating Physicians About Modern-Day Education: Dispelling The Myths and Providing The Facts About Commercially Supported CME PVI, PeerView Institute for Medical Education Please view this PDF file for full CME/CNE/CPE information. You will need Adobe Acrobat software to access this file. Please view this PDF file for full CME/CNE/CPE information. You will need Adobe Acrobat software to access this file. http://media.peerviewpress.com/000136/podcast/pvi/pdf/PPVNE06015CMEinfo.pdf Tue, 30 Nov 2010 13:25:45 -0500 Science, Medicine no 00:00:00 CME, rules, regulations, FDA, promotional activities, ACCME, standards, commercial support, NFEI, bias Vincent A. Miller, MD - Exploring Molecular Targets in Advanced NSCLC: An Interdisciplinary Panel Discussion on Personalizing Care in Advanced NSCLC PVI, PeerView Institute for Medical Education Please be sure to view the accompanying (PDF) file for full CME/CNE/CPE information. Please be sure to view the accompanying (PDF) file for full CME/CNE/CPE information. Please be sure to view the accompanying (PDF) file for full CME/CNE/CPE information. http://media.peerviewpress.com/000136/podcast/pvi/mp3/PPVNE06632e52.mp3 Thu, 25 Nov 2010 12:01:00 -0500 Science & Medicine no 00:33:09 NSCLC, personalized, EGFR, KRAS, MEK, ALK, mutation, wildtype, histology, IHC, FISH, pathology CME/CNE/CPE Information - Exploring Molecular Targets in Advanced NSCLC: An Interdisciplinary Panel Discussion on Personalizing Care in Advanced NSCLC PVI, PeerView Institute for Medical Education Please view this PDF file for full CME/CNE/CPE information. You will need Adobe Acrobat reader software to access this file. Please view this PDF file for full CME/CNE/CPE information. You will need Adobe Acrobat reader software to access this file. Please view this PDF file for full CME/CNE/CPE information. You will need Adobe Acrobat reader software to access this file. http://media.peerviewpress.com/000136/podcast/pvi/pdf/PPVNE06632CMEinfo.pdf Thu, 25 Nov 2010 12:00:00 -0500 Science & Medicine no 00:00:00 NSCLC, personalized, EGFR, KRAS, MEK, ALK, mutation, wildtype, histology, IHC, FISH, pathology Frederick R. Rickles, MD, FACP - Clinical Cases in VTE Prophylaxis and Management: Applying Evidence to Improve Care for the Patient With Cancer PVI, PeerView Institute for Medical Education Please be sure to view the accompanying (PDF) file for full CME/CNE/CPE information. Please be sure to view the accompanying (PDF) file for full CME/CNE/CPE information. Please be sure to view the accompanying (PDF) file for full CME/CNE/CPE information. http://media.peerviewpress.com/000136/podcast/pvi/mp3/PPVNE06454p22.mp3 Fri, 19 Nov 2010 12:01:00 -0500 Science & Medicine no 00:30:01 venous thromboembolism, thrombosis, VTE, PE, DVT, clot, anticoagulant, lung, breast cancer, heparin CME/CNE/CPE Information - Clinical Cases in VTE Prophylaxis and Management: Applying Evidence to Improve Care for the Patient With Cancer PVI, PeerView Institute for Medical Education Please view this PDF file for full CME/CNE/CPE information. You will need Adobe Acrobat reader software to access this file. Please view this PDF file for full CME/CNE/CPE information. You will need Adobe Acrobat reader software to access this file. Please view this PDF file for full CME/CNE/CPE information. You will need Adobe Acrobat reader software to access this file. http://media.peerviewpress.com/000136/podcast/pvi/pdf/PPVNE06454CMEinfo.pdf Fri, 19 Nov 2010 12:00:00 -0500 Science & Medicine no 00:00:00 venous thromboembolism, thrombosis, VTE, PE, DVT, clot, anticoagulant, lung, breast cancer, heparin Hope S. Rugo, MD - Taking Stock of the Current Research on Novel Microtubule-Targeting Therapies in Breast Cancer: Expert Perspectives on Challenges and Opportunities PVI, PeerView Institute for Medical Education Please be sure to view the accompanying (PDF) file for full CME/CNE/CPE information. Please be sure to view the accompanying (PDF) file for full CME/CNE/CPE information. Please be sure to view the accompanying (PDF) file for full CME/CNE/CPE information. http://media.peerviewpress.com/000136/podcast/pvi/mp3/PPVNE06761r128.mp3 Fri, 12 Nov 2010 12:01:00 -0500 Science & Medicine no 00:21:03 microtubule, advanced breast cancer, chemotherapy, epothilones, taxanes, cytotoxics, resistance, nab-paclitaxel, ixabepilone CME/CNE/CPE Information - Taking Stock of the Current Research on Novel Microtubule-Targeting Therapies in Breast Cancer: Expert Perspectives on Challenges and Opportunities PVI, PeerView Institute for Medical Education Please view this PDF file for full CME/CNE/CPE information. You will need Adobe Acrobat reader software to access this file. Please view this PDF file for full CME/CNE/CPE information. You will need Adobe Acrobat reader software to access this file. Please view this PDF file for full CME/CNE/CPE information. You will need Adobe Acrobat reader software to access this file. http://media.peerviewpress.com/000136/podcast/pvi/pdf/PPVNE06761CMEinfo.pdf Fri, 12 Nov 2010 12:00:00 -0500 Science & Medicine no 00:00:00 microtubule, advanced breast cancer, chemotherapy, epothilones, taxanes, cytotoxics, resistance, nab-paclitaxel, ixabepilone Paul G. Richardson, MD - Managing the Myeloma Patient: Upfront and Second-Line Treatment, Special Populations, and Other Clinical Scenarios PVI, PeerView Institute for Medical Education Please be sure to view the accompanying (PDF) file for full CME/CNE/CPE information. Please be sure to view the accompanying (PDF) file for full CME/CNE/CPE information. Please be sure to view the accompanying (PDF) file for full CME/CNE/CPE information. http://media.peerviewpress.com/000136/podcast/pvi/mp3/PPVNE06347p28.mp3 Thu, 28 Oct 2010 12:01:00 -0500 Science & Medicine no 00:35:55 myeloma, stem cell transplant, immunomodulating drugs, lenalidomide, brotezomib, thalidomide, cytogenetic, ASCT, PLD CME/CNE/CPE Information - Managing the Myeloma Patient: Upfront and Second-Line Treatment, Special Populations, and Other Clinical Scenarios PVI, PeerView Institute for Medical Education Please view this PDF file for full CME/CNE/CPE information. You will need Adobe Acrobat reader software to access this file. Please view this PDF file for full CME/CNE/CPE information. You will need Adobe Acrobat reader software to access this file. Please view this PDF file for full CME/CNE/CPE information. You will need Adobe Acrobat reader software to access this file. http://media.peerviewpress.com/000136/podcast/pvi/pdf/PPVNE06347CMEinfo.pdf Thu, 28 Oct 2010 12:00:00 -0500 Science & Medicine no 00:00:00 myeloma, stem cell transplant, immunomodulating drugs, lenalidomide, brotezomib, thalidomide, cytogenetic, ASCT, PLD John P. Leonard, MD - Interpreting New Findings on Hematologic Malignancies: From New Standards to Emerging Therapeutics PVI, PeerView Institute for Medical Education Please be sure to view the accompanying (PDF) file for full CME/CNE/CPE information. Please be sure to view the accompanying (PDF) file for full CME/CNE/CPE information. Please be sure to view the accompanying (PDF) file for full CME/CNE/CPE information. http://media.peerviewpress.com/000136/podcast/pvi/mp3/PPVNE06764s170.mp3 Wed, 13 Oct 2010 12:01:00 -0500 Science & Medicine no 00:58:21 CLL, leukemia, multiple myeloma, NHL, lymphoma, MDS, stem cell tranplantation, HDAC, cytogenetics CME/CNE/CPE Information - Interpreting New Findings on Hematologic Malignancies: From New Standards to Emerging Therapeutics PVI, PeerView Institute for Medical Education Please view this PDF file for full CME/CNE/CPE information. You will need Adobe Acrobat reader software to access this file. Please view this PDF file for full CME/CNE/CPE information. You will need Adobe Acrobat reader software to access this file. Please view this PDF file for full CME/CNE/CPE information. You will need Adobe Acrobat reader software to access this file. http://media.peerviewpress.com/000136/podcast/pvi/pdf/PPVNE06764CMEinfo.pdf Wed, 13 Oct 2010 12:00:00 -0500 Science & Medicine no 00:00:00 CLL, leukemia, multiple myeloma, NHL, lymphoma, MDS, stem cell tranplantation, HDAC, cytogenetics Jorge E. Cortes, MD - Debating the Present and Future of CML Management: An Expanding Therapeutic Paradigm? PVI, PeerView Institute for Medical Education Please be sure to view the accompanying (PDF) file for full CME/CNE/CPE information. Please be sure to view the accompanying (PDF) file for full CME/CNE/CPE information. Please be sure to view the accompanying (PDF) file for full CME/CNE/CPE information. http://media.peerviewpress.com/000136/podcast/pvi/mp3/PPVNE06813e48.mp3 Fri, 17 Sep 2010 12:01:00 -0500 Science & Medicine no 00:30:49 myeloid leukemia, CML, imatinib, dasatinib, nilotinib, TKI, targeted, second generation, relapsed, refractory CME/CNE/CPE Information - Debating the Present and Future of CML Management: An Expanding Therapeutic Paradigm? PVI, PeerView Institute for Medical Education Please view this PDF file for full CME/CNE/CPE information. You will need Adobe Acrobat reader software to access this file. Please view this PDF file for full CME/CNE/CPE information. You will need Adobe Acrobat reader software to access this file. Please view this PDF file for full CME/CNE/CPE information. You will need Adobe Acrobat reader software to access this file. http://media.peerviewpress.com/000136/podcast/pvi/pdf/PPVNE06813CMEinfo.pdf Fri, 17 Sep 2010 12:00:00 -0500 Science & Medicine no 00:00:00 myeloid leukemia, CML, imatinib, dasatinib, nilotinib, TKI, targeted, second generation, relapsed, refractory Harry P. Erba, MD, PhD - Can Modern Therapy Improve Outcomes in Adult AML? PVI, PeerView Institute for Medical Education Please be sure to view the accompanying (PDF) file for full CME/CNE/CPE information. Please be sure to view the accompanying (PDF) file for full CME/CNE/CPE information. Please be sure to view the accompanying (PDF) file for full CME/CNE/CPE information. http://media.peerviewpress.com/000136/podcast/pvi/mp3/PPVNE06493r115.mp3 Wed, 11 Aug 2010 12:01:00 -0500 Science & Medicine no 00:31:44 AML, acute myeloid luekemia, cytogenetics, HSCT, remission, cytarabine, tyrosine kinase, maintenance, relapse CME/CNE/CPE Information - Can Modern Therapy Improve Outcomes in Adult AML? PVI, PeerView Institute for Medical Education Please view this PDF file for full CME/CNE/CPE information. You will need Adobe Acrobat reader software to access this file. Please view this PDF file for full CME/CNE/CPE information. You will need Adobe Acrobat reader software to access this file. Please view this PDF file for full CME/CNE/CPE information. You will need Adobe Acrobat reader software to access this file. http://media.peerviewpress.com/000136/podcast/pvi/pdf/PPVNE06493CMEinfo.pdf Wed, 11 Aug 2010 12:00:00 -0500 Science & Medicine no 00:00:00 AML, acute myeloid luekemia, cytogenetics, HSCT, remission, cytarabine, tyrosine kinase, maintenance, relapse